168 related articles for article (PubMed ID: 38394550)
21. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis.
Aktaş Karabay E; Aksu Çerman A
An Bras Dermatol; 2020; 95(2):187-193. PubMed ID: 32113677
[TBL] [Abstract][Full Text] [Related]
22. The Effect of Skin Sebum, pH, and Moisture on Demodex Infestation in Acne Vulgaris and Rosacea Patients.
Turan N; Kapıcıoğlu Y; Saraç G
Turkiye Parazitol Derg; 2017 Sep; 41(3):143-147. PubMed ID: 29035242
[TBL] [Abstract][Full Text] [Related]
23. Novel device-based acne treatments: comparison of a 1450-nm diode laser and microneedling radiofrequency on mild-to-moderate acne vulgaris and seborrhoea in Korean patients through a 20-week prospective, randomized, split-face study.
Kwon HH; Park HY; Choi SC; Bae Y; Jung JY; Park GH
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):639-644. PubMed ID: 29178495
[TBL] [Abstract][Full Text] [Related]
24. Microbotox: A prospective evaluation of dermatological improvement in patients with mild-to-moderate acne and erythematotelangiectatic rosacea.
Calvisi L; Diaspro A; Sito G
J Cosmet Dermatol; 2022 Sep; 21(9):3747-3753. PubMed ID: 35312149
[TBL] [Abstract][Full Text] [Related]
25. Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice.
Fabi SG; Park JY; Goldie K; Wu W
Aesthet Surg J; 2023 Aug; 43(9):1015-1024. PubMed ID: 36857534
[TBL] [Abstract][Full Text] [Related]
26. New and emerging drugs for the treatment of acne vulgaris in adolescents.
Valente Duarte De Sousa IC
Expert Opin Pharmacother; 2019 Jun; 20(8):1009-1024. PubMed ID: 30848961
[TBL] [Abstract][Full Text] [Related]
27. The influence of cosmetics dedicated to oily and acne-prone skin on skin parameters.
Zdrada J; Odrzywołek W; Stolecka-Warzecha A; Wilczyński S; Błońska-Fajfrowska B
J Cosmet Dermatol; 2022 Nov; 21(11):6092-6099. PubMed ID: 35665586
[TBL] [Abstract][Full Text] [Related]
28. The fatty acid composition of the surface skin fats ('sebum') in acne vulgaris and seborrheic dermatitis.
BOUGHTON B; MACKENNA RM; WHEATLEY VR; WORMALL A
J Invest Dermatol; 1959 Aug; 33():57-64. PubMed ID: 13803220
[No Abstract] [Full Text] [Related]
29. Complementary therapies for acne vulgaris.
Cao H; Yang G; Wang Y; Liu JP; Smith CA; Luo H; Liu Y
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009436. PubMed ID: 25597924
[TBL] [Abstract][Full Text] [Related]
30. Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management.
Daniele SG; Kim SR; Grada A; Moore AY; Suozzi KC; Bunick CG
Am J Clin Dermatol; 2023 Mar; 24(2):199-223. PubMed ID: 36539678
[TBL] [Abstract][Full Text] [Related]
31. Application of Botulinum Neurotoxin in Female Sexual and Genitourinary Dysfunction: A Review of Current Practices.
Dick B; Natale C; Reddy A; Akula KP; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Jan; 9(1):57-63. PubMed ID: 32238326
[TBL] [Abstract][Full Text] [Related]
32. The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris.
Del Rosso JQ; Kircik L
J Dermatolog Treat; 2024 Dec; 35(1):2298878. PubMed ID: 38192024
[No Abstract] [Full Text] [Related]
33. Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement.
Baldwin H; Farberg A; Frey C; Hartman C; Lain E; Meltzer R; Draelos Z
J Drugs Dermatol; 2023 Jun; 22(6):582-587. PubMed ID: 37276154
[TBL] [Abstract][Full Text] [Related]
34. Minocycline for acne vulgaris: efficacy and safety.
Garner SE; Eady EA; Popescu C; Newton J; Li WA
Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
[TBL] [Abstract][Full Text] [Related]
35. Long-term effect of azelaic acid peel on sebum production in acne.
Szymańska A; Budzisz E; Erkiert-Polguj A
Dermatol Ther; 2022 Jan; 35(1):e15186. PubMed ID: 34731527
[TBL] [Abstract][Full Text] [Related]
36. Effects of Topical Hydrogen Purification on Skin Parameters and Acne Vulgaris in Adult Women.
Chilicka K; Rogowska AM; Szyguła R
Healthcare (Basel); 2021 Feb; 9(2):. PubMed ID: 33535651
[TBL] [Abstract][Full Text] [Related]
37. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
Wortzman MS; Pickett A
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
[TBL] [Abstract][Full Text] [Related]
38. Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
Naumann M; Dressler D; Hallett M; Jankovic J; Schiavo G; Segal KR; Truong D
Toxicon; 2013 Jun; 67():141-52. PubMed ID: 23178324
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin in urology: a review of clinical potential in the treatment of urologic and sexual conditions.
Chung E
Expert Opin Biol Ther; 2015 Jan; 15(1):95-102. PubMed ID: 25347039
[TBL] [Abstract][Full Text] [Related]
40. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
